Optimizing the management of benign prostatic hyperplasia
One of the challenges facing primary care physicians and specialists as the population ages is the management of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). While as many as 18% of men in their 40s report bother from an enlarged prostate, that figure rises dr...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-04-01
|
Series: | Therapeutic Advances in Urology |
Online Access: | https://doi.org/10.1177/1756287212437361 |
id |
doaj-aca00b4331e34a1ba5c22790463e9847 |
---|---|
record_format |
Article |
spelling |
doaj-aca00b4331e34a1ba5c22790463e98472020-11-25T02:53:12ZengSAGE PublishingTherapeutic Advances in Urology1756-28721756-28802012-04-01410.1177/1756287212437361Optimizing the management of benign prostatic hyperplasiaDean S. EltermanJack BarkinSteven A. KaplanOne of the challenges facing primary care physicians and specialists as the population ages is the management of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). While as many as 18% of men in their 40s report bother from an enlarged prostate, that figure rises dramatically, whereby 50% of men in their 50s and 90% of men in their 90s will complain of bothersome symptoms related to an enlarged prostate. Studies have shown that BPH is a progressive disease, which if left untreated can result in worsening of symptoms, acute urinary retention and renal failure. Until about 20 years ago the only management option available to urologists was surgery. In the early 1990s medical therapy emerged as the predominant treatment for BPH. Therapy may be tailored to target symptoms and progression of disease.https://doi.org/10.1177/1756287212437361 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dean S. Elterman Jack Barkin Steven A. Kaplan |
spellingShingle |
Dean S. Elterman Jack Barkin Steven A. Kaplan Optimizing the management of benign prostatic hyperplasia Therapeutic Advances in Urology |
author_facet |
Dean S. Elterman Jack Barkin Steven A. Kaplan |
author_sort |
Dean S. Elterman |
title |
Optimizing the management of benign prostatic hyperplasia |
title_short |
Optimizing the management of benign prostatic hyperplasia |
title_full |
Optimizing the management of benign prostatic hyperplasia |
title_fullStr |
Optimizing the management of benign prostatic hyperplasia |
title_full_unstemmed |
Optimizing the management of benign prostatic hyperplasia |
title_sort |
optimizing the management of benign prostatic hyperplasia |
publisher |
SAGE Publishing |
series |
Therapeutic Advances in Urology |
issn |
1756-2872 1756-2880 |
publishDate |
2012-04-01 |
description |
One of the challenges facing primary care physicians and specialists as the population ages is the management of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). While as many as 18% of men in their 40s report bother from an enlarged prostate, that figure rises dramatically, whereby 50% of men in their 50s and 90% of men in their 90s will complain of bothersome symptoms related to an enlarged prostate. Studies have shown that BPH is a progressive disease, which if left untreated can result in worsening of symptoms, acute urinary retention and renal failure. Until about 20 years ago the only management option available to urologists was surgery. In the early 1990s medical therapy emerged as the predominant treatment for BPH. Therapy may be tailored to target symptoms and progression of disease. |
url |
https://doi.org/10.1177/1756287212437361 |
work_keys_str_mv |
AT deanselterman optimizingthemanagementofbenignprostatichyperplasia AT jackbarkin optimizingthemanagementofbenignprostatichyperplasia AT stevenakaplan optimizingthemanagementofbenignprostatichyperplasia |
_version_ |
1724726129716101120 |